Caprotec Bioanalytics last week launched new caproKits for C2 CAMP, dasatinib, and biotin capping.
The launch of the three kits brings the total of commercially available caproKits to 10 and expands the company's portfolio into the areas of signal transduction, epigenetics, and proteases. CaproKits are based on Caprotec's Capture Compound Mass Spectrometry technology, which allows the isolation and identification of defined protein classes, reducing proteome complexity to enable easier analysis of target molecules, according to the company.